Moors & Cabot’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-610
| Closed | -$12K | – | 859 |
|
|
2022
Q1 | $12K | Hold |
610
| – | – | ﹤0.01% | 847 |
|
|
2021
Q4 | $11K | Sell |
610
-40
| -6% | -$721 | ﹤0.01% | 850 |
|
|
2021
Q3 | $24K | Sell |
650
-79
| -11% | -$2.92K | ﹤0.01% | 827 |
|
|
2021
Q2 | $43K | Buy |
729
+23
| +3% | +$1.36K | ﹤0.01% | 792 |
|
|
2021
Q1 | $47K | Buy |
706
+16
| +2% | +$1.07K | ﹤0.01% | 743 |
|
|
2020
Q4 | $41K | Sell |
690
-376
| -35% | -$22.3K | ﹤0.01% | 712 |
|
|
2020
Q3 | $84K | Hold |
1,066
| – | – | 0.01% | 661 |
|
|
2020
Q2 | $67K | Buy |
1,066
+16
| +2% | +$1.01K | 0.01% | 634 |
|
|
2020
Q1 | $55K | Sell |
1,050
-16
| -2% | -$838 | 0.01% | 563 |
|
|
2019
Q4 | $128K | Buy |
1,066
+232
| +28% | +$27.9K | 0.01% | 590 |
|
|
2019
Q3 | $152K | Buy |
834
+634
| +317% | +$116K | 0.02% | 565 |
|
|
2019
Q2 | $25K | Buy |
+200
| New | +$25K | ﹤0.01% | 542 |
|